Ling-ling Yang - JoVE Visualize

Showing results (171-180 of 182) with videos related to

Pageof 19

Sort By:

Journal of Medicinal Chemistry|November 27, 2024

Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA AgentsKai Liu, Jing Xia, Yun Li, et al.

Journal of Medicinal Chemistry|October 4, 2023

Discovery of 2-Aminothiazole-4-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors by Mimicking Carbapenem Hydrolysate BindingYu-Hang Yan, Ting-Ting Zhang, Rong Li, et al.

Acta Pharmacologica Sinica|April 3, 2015

2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed miceJin Zhang, Li-na Zhang, Dong-mei Chen, et al.

Molecular Carcinogenesis|April 17, 2023

Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancerXiao-Rong Yang, Can Pi, Yi-Chen Zhang, et al.

Water Research|June 25, 2022

Efficient decomposition of perfluorooctane sulfonate by electrochemical activation of peroxymonosulfate in aqueous solution: Efficacy, reaction mechanism, active sites, and application potentialMeng Li, Yu-Ting Jin, Dan-Yang Cao, et al.

Journal of Medicinal Chemistry|August 19, 2016

Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal ModelGuo-Bo Li, Shuang Ma, Ling-Ling Yang, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2025

GNE-317 Reverses MSN-Mediated Proneural-to-Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTORYong-Chang Yang, Xing-Yu Jin, Ling-Ling Yang, et al.

Journal of Advanced Research|June 21, 2026

Physical exercise mitigates amyloid beta-driven muscle degeneration in Alzheimer's diseaseLing-Ling Yang, Ya-Xi Luo, Dan Song, et al.

NPJ Precision Oncology|September 19, 2022

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysisChao Zhang, Hua-Fei Chen, Shi Yan, et al.

Journal of Medicinal Chemistry|March 29, 2012

Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.

Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:

Pageof 19

Journal of Medicinal Chemistry|November 27, 2024

Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA AgentsKai Liu, Jing Xia, Yun Li, et al.

Journal of Medicinal Chemistry|October 4, 2023

Discovery of 2-Aminothiazole-4-carboxylic Acids as Broad-Spectrum Metallo-β-lactamase Inhibitors by Mimicking Carbapenem Hydrolysate BindingYu-Hang Yan, Ting-Ting Zhang, Rong Li, et al.

Acta Pharmacologica Sinica|April 3, 2015

2-(3-Benzoylthioureido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid ameliorates metabolic disorders in high-fat diet-fed miceJin Zhang, Li-na Zhang, Dong-mei Chen, et al.

Molecular Carcinogenesis|April 17, 2023

Heterogeneity in the immune microenvironment of bone metastasis in driver-positive non-small cell lung cancerXiao-Rong Yang, Can Pi, Yi-Chen Zhang, et al.

Water Research|June 25, 2022

Efficient decomposition of perfluorooctane sulfonate by electrochemical activation of peroxymonosulfate in aqueous solution: Efficacy, reaction mechanism, active sites, and application potentialMeng Li, Yu-Ting Jin, Dan-Yang Cao, et al.

Journal of Medicinal Chemistry|August 19, 2016

Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal ModelGuo-Bo Li, Shuang Ma, Ling-Ling Yang, et al.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 8, 2025

GNE-317 Reverses MSN-Mediated Proneural-to-Mesenchymal Transition and Suppresses Chemoradiotherapy Resistance in Glioblastoma via PI3K/mTORYong-Chang Yang, Xing-Yu Jin, Ling-Ling Yang, et al.

Journal of Advanced Research|June 21, 2026

Physical exercise mitigates amyloid beta-driven muscle degeneration in Alzheimer's diseaseLing-Ling Yang, Ya-Xi Luo, Dan Song, et al.

NPJ Precision Oncology|September 19, 2022

Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysisChao Zhang, Hua-Fei Chen, Shi Yan, et al.

Journal of Medicinal Chemistry|March 29, 2012

Discovery of the novel potent and selective FLT3 inhibitor 1-{5-[7-(3- morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and its anti-acute myeloid leukemia (AML) activities in vitro and in vivoWei-Wei Li, Xiao-Yan Wang, Ren-Lin Zheng, et al.

Pageof 19